Go to Page # Page of 21

Discovery of Cardioprotective Prokineticin Receptor Agonist: Anti-Cancer Drug Induced Cardiotoxicity

 Canan Nebigil
  31st-Dec-2018
Description: Dexrazoxane is the only FDA & EMA approved cardioprotective agent to prevent anticancer drug-induced cardiotoxicity Prokineticin/PKR1 is ideal candidate to regenerate damaged heart.
Views: 2251
Domain: Medical
Category: Biology
Contents:
Discovery of cardioprotective
prokineticin receptor agonist: anti-cancer
drug induced cardiotoxicity
Canan Nebigil, DR2, CNRS
nebigil@unistra.fr
UMR7242, ESBS
AnP, 30 May, 2018

Most of the anticancer treatments
induce cardiotoxicity
Antracyclines

Radiation

Cardiotoxicity
HER-2
inhibitors
VEGF
inhibitors

Cisplatin
Vinca
alkaloids
bleomycin

Cardiovascular side effects of anti-cancer
treatment ... See more

Recent Presentations

...
25 March, 2019
...
24 March, 2019
...
22 March, 2019